Ondansetron Orally Disintegrating Tablets 8 mg

DRUG2 trials

Sponsors

Mylan Pharmaceuticals Inc

Conditions

Healthy

Phase 1

Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

CompletedNCT00649363

Mylan Pharmaceuticals IncHealthy

Start: 2005-07-31End: 2005-07-31Updated: 2024-04-24

Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

CompletedNCT00648804

Mylan Pharmaceuticals IncHealthy

Start: 2005-07-31End: 2005-07-31Updated: 2024-04-24